← Leaderboards
Richard Johnson
Saros Therapeutics Inc
$2,046,919
Attributed
$2,046,919
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2023–24$2M$1.5M$1M$500K$0
'23
'24
Funding mix
By agency
NIH$2,046,919 · 1
By mechanism
R44$2,046,919 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Agonist”
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- Suma Babu · Massachusetts General Hospital$9,298,517
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Jennifer Lapek · Scripps Institution Of Oceanography$6,359,752
Research focus
AgonistAnti-Tumor Immune ResponseAntitumor ResponseBenchmarkingBiodistributionBiologicalBiopsy SpecimenBlood Chemical AnalysisBreast Cancer PatientCancer ImmunotherapyCancer PatientCancer TypeCell MembraneCellsCell TypeCharacteristicsClinical DevelopmentClinical ResearchClinical TrialsClinic ReadyComparative EfficacyComplexContractsAcceleration